Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...
Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...
Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...
Biomedical engineers from the University of Melbourne, Australia have invented a 3D printing system, or bioprinter, capa...
ATLATL Hong Kong Innovation Center, a new state-of-the-art research facility designed to provide immediate, move-in-read...
Japan-based Ono Pharmaceutical Co. has entered into a license agreement with LigaChem Biosciences, Inc., in South Korea,...
Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technolo...
This exciting forum will gather the field to discuss the latest advancements in NGS, biomarker development, clinical tri...
American pharmaceutical firm Eli Lilly and Company has announced a $4.5 billion investment to create the Lilly...
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...
Bridge Biotherapeutics, a startup based in the Republic of Korea and the US, has entered into a joint research agreement...
Advancements in Drug Delivery Technologies Innovative drug delivery systems have emerged to address the limitations of ...
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland&rsq...
AstraZeneca K.K. and United Immunity have signed an agreement for joint research on next-generation lipid nanoparticles ...
Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised ...
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop FG-M701, a ...
Oncocross, a Seoul-based artificial intelligence (AI) drug discovery and development biotech startup, has signed a joint...
Japan-based Shionogi & Co. and Maze Therapeutics, Inc., in the US, have completed an exclusive worldwide license agr...
